Menu
Currency
GWAS Study

A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo.

Skuladottir AT, Bjornsdottir G, Nawaz MS et al.

34620984 PubMed ID
GWAS Study Type
942613 Participants
66 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SA
Skuladottir AT
BG
Bjornsdottir G
NM
Nawaz MS
PH
Petersen H
RS
Rognvaldsson S
MK
Moore KHS
OP
Olafsson PI
MS
Magnusson SH
BA
Bjornsdottir A
SO
Sveinsson OA
SG
Sigurdardottir GR
SS
Saevarsdottir S
IE
Ivarsdottir EV
SL
Stefansdottir L
GB
Gunnarsson B
MJ
Muhlestein JB
KK
Knowlton KU
JD
Jones DA
NL
Nadauld LD
HA
Hartmann AM
RD
Rujescu D
SM
Strupp M
WG
Walters GB
TT
Thorgeirsson TE
JI
Jonsdottir I
HH
Holm H
TG
Thorleifsson G
GD
Gudbjartsson DF
SP
Sulem P
SH
Stefansson H
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Vertigo is the leading symptom of vestibular disorders and a major risk factor for falls. In a genome-wide association study of vertigo (Ncases = 48,072, Ncontrols = 894,541), we uncovered an association with six common sequence variants in individuals of European ancestry, including missense variants in ZNF91, OTOG, OTOGL, and TECTA, and a cis-eQTL for ARMC9. The association of variants in ZNF91, OTOGL, and OTOP1 was driven by an association with benign paroxysmal positional vertigo. Using previous reports of sequence variants associating with age-related hearing impairment and motion sickness, we found eight additional variants that associate with vertigo. Although disorders of the auditory and the vestibular system may co-occur, none of the six genome-wide significant vertigo variants were associated with hearing loss and only one was associated with age-related hearing impairment. Our results uncovered sequence variants associating with vertigo in a genome-wide association study and implicated genes with known roles in inner ear development, maintenance, and disease.

48,072 European ancestry cases, 894,541 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

942613
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Iceland, U.K., U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.